A Prospective, Blinded, Randomized, Controlled Clinical Trial of Topical Negative Pressure Use in Skin Grafting

Abstract

Topical negative pressure has been demonstrated to improve graft take in a number of noncomparative studies. This study aimed to assess whether split-thickness skin graft take is improved qualitatively or quantitatively with topical negative pressure therapy compared with standard bolster dressings. A blinded, prospective, randomized trial was conducted of 22 adult inpatients of Liverpool Hospital between July of 2001 and July of 2002 who had wounds requiring skin grafting. After grafting, each wound half was randomized to receive either a standard bolster dressing or a topical negative pressure dressing. Skin graft assessment was performed at 2 weeks by a single observer blinded to the randomization. Two patients were lost to follow-up and were excluded from the study. There were 20 patients (12 men and eightwomen) in the study group. The median patient age was 64 years (range, 27 to 88 years), and the mean wound size was 128 cm2 (range, 35 to 450 cm2). The wound exposed subcutaneous fat in eight patients, muscle in six patients, paratenon in four patients, and deep fascia in two patients. At 2 weeks, wounds that received a topical negative pressure dressing had a greater degree of epithelialization in six cases (30 percent), the same degree of epithelialization in nine cases (45 percent), and less epithelialization in five cases (25 percent) compared with their respective control wounds. Graft quality following topical negative pressure therapy was subjectively determined to be better in 10 cases (50 percent), equivalent in seven cases (35 percent), and worse in three cases (15 percent). Although the quantitative graft take was not significant, the qualitative graft take was found to be significantly better with the use of topical negative pressure therapy (p < 0.05). Topical negative pressure significantly improved the qualitative appearance of split-thickness skin grafts as compared with standard bolster dressings.

Negative pressure wound therapy: eleven-year experience at a tertiary care hospital

“…36,37 We also used NPWT over skin grafts in 83 patients with excellent results. The prevalence of pressure sores in hospitalized patients has been reported to be from 14% to 21% over the last decade and the overall annual cost has recently been estimated to be between 5 billion and 8.5 billion dollars.…”

Innovation in wound management with disposable, portable, cost-effective and non-powered NPWT device: Experience in general surgery

“…[6] NPWT proved to be better than moist gauze dressings in diabetic feet, [7] effective in the treatment of chronic leg ulcers [8] and also showed better graft take p < .05. [9] Previously NPWT were always applied during hospital admission. [1] With better primary care facilities, they can be managed at home.…”

Terapia de vacío como adyuvante para el uso de sustitutos dérmicos monocapa

“…Su uso se extendió rápidamente para el tratamiento de otros defectos como heridas crónicas, defectos sobre hueso, pie diabético (6) e incluso se ha utilizado como material de relleno en defectos pequeños (7). Algunos autores han ampliado sus indicaciones a la mejora en la capacidad de prendimiento de los injertos de piel parcial y la calidad de la cobertura gracias a que permite la inoculación de nutrientes desde el lecho receptor al injerto, estabilizando y homogeneizando el contacto entre ambas superficies (8).…”